Enanta Pharmaceuticals
ENTA
#7333
Rank
C$0.61 B
Marketcap
C$21.48
Share price
-3.08%
Change (1 day)
134.58%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: C$0.61 Billion

As of December 2025 Enanta Pharmaceuticals has a market cap of C$0.61 Billion. This makes Enanta Pharmaceuticals the world's 7333th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025C$0.61 B239.17%
2024C$0.18 B-30.46%
2023C$0.26 B-79.98%
2022C$1.31 B-32.82%
2021C$1.95 B81.31%
2020C$1.07 B-32.57%
2019C$1.59 B-14.76%
2018C$1.87 B32.89%
2017C$1.41 B64.61%
2016C$0.85 B-0.43%
2015C$0.86 B-21.62%
2014C$1.09 B110.53%
2013C$0.52 B

End of Day market cap according to different sources

On Dec 23rd, 2025 the market cap of Enanta Pharmaceuticals was reported to be:

C$0.61 Billion
by Nasdaq info icon info icon
C$0.61 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AbbVie
ABBV
C$552.85 B 89,077.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$677.85 B 109,240.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$160.97 B 25,865.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$358.71 B 57,762.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$151.08 B 24,269.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$365.00 B 58,775.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland